NYSE: DHR
Danaher Corp Stock

$210.01-2.12 (-1%)
Updated Feb 6, 2025
DHR Price
$210.01
Fair Value Price
N/A
Market Cap
$151.69B
52 Week Low
$209.10
52 Week High
$281.70
P/E
39.7x
P/B
2.96x
P/S
9.94x
PEG
1.59x
Dividend Yield
0.39%
Revenue
$20.03B
Earnings
$3.89B
Gross Margin
59.6%
Operating Margin
23.1%
Profit Margin
19.4%
Debt to Equity
0.57
Operating Cash Flow
$6B
Beta
0.83
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

DHR Overview

Danaher Corporation is a diversified conglomerate that designs, manufactures, and markets professional, medical, industrial, and commercial products and services. Its segments are Life Sciences, Diagnostics, and Environmental & Applied Solutions. Originally organized in 1969 as a Massachusetts real estate investment trust (REIT) and known as DMG until 1984, the company is headquartered in Washington, D.C.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine DHR's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

B
Value
C
Growth
C
Momentum
C
Sentiment
C
Safety
B
Financials
C
Artificial Intelligence
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Diagnostic & Research

Industry Rating
B
DHR
Ranked
#20 of 54

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$122.80B
$175.14B
$27.83B
View Top Diagnostic & Research Stocks

Be the first to know about important DHR news, forecast changes, insider trades & much more!

DHR News

Overview

Due Diligence Score

Industry Average (24)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how DHR scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

DHR ($210.01) is trading above its intrinsic value of $74.21, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
DHR is poor value based on its earnings relative to its share price (39.7x), compared to the US market average (31.69x)
P/E vs Market Valuation
DHR is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more DHR due diligence checks available for Premium users.

Valuation

DHR price to earnings (PE)

For valuing profitable companies with steady earnings

Company
39.7x
Industry
23.3x
Market
31.69x
DHR is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
DHR is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

DHR price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
2.96x
Industry
4.08x
DHR is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

DHR price to earnings growth (PEG)

For valuing profitable companies with growth potential

DHR is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

DHR's financial health

Profit margin

Revenue
$5.8B
Net Income
$818.0M
Profit Margin
14.1%
DHR's Earnings (EBIT) of $4.63B... subscribe to Premium to read more.
Interest Coverage Financials
DHR's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$80.6B
Liabilities
$29.3B
Debt to equity
0.57
DHR's short-term assets ($10.06B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
DHR's long-term liabilities ($21.97B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
DHR's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
DHR's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$1.5B
Investing
-$606.0M
Financing
-$845.0M
DHR's operating cash flow ($6.29B)... subscribe to Premium to read more.
Debt Coverage Financials

DHR vs Diagnostic & Research Stocks

TickerZen RatingMarket Cap1d %P/EP/B
DHRC$151.69B-1.00%39.70x2.96x
TMOB$219.06B-1.66%35.82x4.47x
AC$42.17B-0.24%33.25x7.15x
IQVC$38.11B+2.20%27.23x5.47x
IDXXC$37.71B-1.71%43.99x23.31x

Danaher Stock FAQ

What is Danaher's quote symbol?

(NYSE: DHR) Danaher trades on the NYSE under the ticker symbol DHR. Danaher stock quotes can also be displayed as NYSE: DHR.

If you're new to stock investing, here's how to buy Danaher stock.

What is the 52 week high and low for Danaher (NYSE: DHR)?

(NYSE: DHR) Danaher's 52-week high was $281.70, and its 52-week low was $209.10. It is currently -25.45% from its 52-week high and 0.44% from its 52-week low.

How much is Danaher stock worth today?

(NYSE: DHR) Danaher currently has 722,275,141 outstanding shares. With Danaher stock trading at $210.01 per share, the total value of Danaher stock (market capitalization) is $151.69B.

Danaher stock was originally listed at a price of $7.89 in Dec 31, 1997. If you had invested in Danaher stock at $7.89, your return over the last 27 years would have been 2,561.39%, for an annualized return of 12.92% (not including any dividends or dividend reinvestments).

How much is Danaher's stock price per share?

(NYSE: DHR) Danaher stock price per share is $210.01 today (as of Feb 6, 2025).

What is Danaher's Market Cap?

(NYSE: DHR) Danaher's market cap is $151.69B, as of Feb 7, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Danaher's market cap is calculated by multiplying DHR's current stock price of $210.01 by DHR's total outstanding shares of 722,275,141.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.